StockWatch
·
Pharmaceuticals
Board Meeting28 Oct 2026, 04:03 pm

Ambalal Sarabhai Enterprises Ltd Board Meeting on Nov 5, 2026

AI Summary

Ambalal Sarabhai Enterprises Ltd has announced that its Board of Directors will convene on November 5, 2026. The primary agenda item is to consider and approve the Unaudited Financial Results (Standalone & Consolidated) for the quarter and half-year ended September 30, 2026, along with the Auditors' Limited Review Report. Additionally, the board may discuss other matters as they deem fit. The company also informed that the trading window for its securities will remain closed from October 1, 2026, to November 7, 2026, inclusive, in accordance with its insider trading code of conduct.

Key Highlights

  • Board meeting scheduled for November 5, 2026.
  • To approve Unaudited Financial Results for Q2 FY27.
  • Limited Review Report from Auditors to be considered.
  • Trading window closed from October 1 to November 7, 2026.